Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moyer

Showing results (221-230 of 251) with videos related to

Pageof 26
Sort By:
Blood Advances|March 31, 2026
Rapid Germline Testing with Hair Root Bulb-Derived DNA for Hereditary Predisposition and Inherited Marrow Failure StatesEmma C St Martin, Abhishek A Mangaonkar, Ann M Moyer, et al.
The Pharmacogenomics Journal|October 21, 2021
Nine-gene pharmacogenomics profile service: The Mayo Clinic experienceEric T Matey, Ashley Kate Ragan, Lance J Oyen, et al.
Archives of Pathology & Laboratory Medicine|March 23, 2022
Late Complications of COVID-19Anja C Roden, Jennifer M Boland, Tucker F Johnson, et al.
Clinical Pharmacology and Therapeutics|September 5, 2023
PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on ReportingAmy J Turner, Charity Nofziger, Bronwyn E Ramey, et al.
Archives of Pathology & Laboratory Medicine|December 2, 2014
The Cancer Genomics Resource List 2014Mary M Zutter, Kenneth J Bloom, Liang Cheng, et al.
Pharmacogenetics and Genomics|May 15, 2013
Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751Federico Innocenti, Jacqueline Ramírez, Jennifer Obel, et al.
Genetic Testing and Molecular Biomarkers|February 12, 2015
Relationship of genetic variation in the serotonin transporter gene (SLC6A4) and congenital and acquired cardiovascular diseasesAnn M Moyer, Denise L Walker, Rajeswari Avula, et al.
Clinical Pharmacology and Therapeutics|June 5, 2025
Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining ChallengesD Max Smith, Michael P Douglas, Christina L Aquilante, et al.
Clinical Pharmacology and Therapeutics|January 31, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 UpdateMaud Maillard, Matthias Schwab, Michelle Whirl-Carrillo, et al.
American Journal of Hematology|March 6, 2025
Clinical Outcomes and Treatment Strategies of Adult Transplant-Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High-Risk CriteriaAldo A Acosta-Medina, Meera Sridharan, Ronald S Go, et al.
Pageof 26

Showing results (221-230 of 251) with videos related to

Sort By:
Pageof 26
Blood Advances|March 31, 2026
Rapid Germline Testing with Hair Root Bulb-Derived DNA for Hereditary Predisposition and Inherited Marrow Failure StatesEmma C St Martin, Abhishek A Mangaonkar, Ann M Moyer, et al.
The Pharmacogenomics Journal|October 21, 2021
Nine-gene pharmacogenomics profile service: The Mayo Clinic experienceEric T Matey, Ashley Kate Ragan, Lance J Oyen, et al.
Archives of Pathology & Laboratory Medicine|March 23, 2022
Late Complications of COVID-19Anja C Roden, Jennifer M Boland, Tucker F Johnson, et al.
Clinical Pharmacology and Therapeutics|September 5, 2023
PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on ReportingAmy J Turner, Charity Nofziger, Bronwyn E Ramey, et al.
Archives of Pathology & Laboratory Medicine|December 2, 2014
The Cancer Genomics Resource List 2014Mary M Zutter, Kenneth J Bloom, Liang Cheng, et al.
Pharmacogenetics and Genomics|May 15, 2013
Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751Federico Innocenti, Jacqueline Ramírez, Jennifer Obel, et al.
Genetic Testing and Molecular Biomarkers|February 12, 2015
Relationship of genetic variation in the serotonin transporter gene (SLC6A4) and congenital and acquired cardiovascular diseasesAnn M Moyer, Denise L Walker, Rajeswari Avula, et al.
Clinical Pharmacology and Therapeutics|June 5, 2025
Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining ChallengesD Max Smith, Michael P Douglas, Christina L Aquilante, et al.
Clinical Pharmacology and Therapeutics|January 31, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 UpdateMaud Maillard, Matthias Schwab, Michelle Whirl-Carrillo, et al.
American Journal of Hematology|March 6, 2025
Clinical Outcomes and Treatment Strategies of Adult Transplant-Associated Thrombotic Microangiopathy: External Validation of Harmonizing Definitions and High-Risk CriteriaAldo A Acosta-Medina, Meera Sridharan, Ronald S Go, et al.
Pageof 26